Related content

A deletion in chromosome 11q may predict the response to anthracycline-based chemotherapy in patients with early node-negative breast cancer

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Anthracycline benefits vastly restricted in breast cancer

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Trastuzumab without an anthracycline: better for early breast cancer

By  

Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Left Ventricular Diastolic Dysfunction in Diabetic Patients: Pathophysiology and Therapeutic Implications

By Tsujino Takeshi   Kawasaki Daizo   Masuyama Tohru  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 219-230

Adis International

Access to resources Recommend Favorite

Effect of Creatinine Clearance on Patterns of Toxicity in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer

By Hurria Arti   Hurria Anju   Brogan Kelly   Panageas Katherine S.   Pearce Carol   Norton Larry   Jakubowski Ann   Howard Jane   Hudis Clifford  

Drugs & Aging, Vol. 22, Iss. 9, 2005-01 ,pp. : 785-791

Adis International

Access to resources Recommend Favorite